Medicines and driving: evaluation of training and software support for patient counselling by pharmacists
- PMID: 22678812
- DOI: 10.1007/s11096-012-9658-7
Medicines and driving: evaluation of training and software support for patient counselling by pharmacists
Abstract
Background: The consumption of some psychotropic medicines has a negative effect on the fitness to drive. Pharmacists are expected to give useful advice to patients on their participation in traffic. However, almost no information is available on this topic.
Objective: To assess the effect of training and implementation of new dispensing guidelines with regard to driving-impairing medicines, in two types of dispensing support tools. User acceptance was measured as well as the effect on pharmacists' attitudes & awareness, self-reported behaviour and knowledge.
Setting: Pharmacists from East Flanders in Belgium.
Methods: Two intervention groups and a control group participated. The intervention groups followed a training and were provided with a dispensing support tool containing information on the effect of medicines on driving ability, which was either stand-alone (USB stick) or integrated into the daily used software (ViaNova). The three groups filled out a questionnaire prior to and after the intervention period.
Main outcome measure: Answers to a pre/post-questionnaire on attitudes and awareness, self-reported behaviour, knowledge and user acceptance.
Results: Many pharmacists were already strongly interested in the topic at the beginning of the study. Positive changes in attitude, self-reported behaviour and knowledge were measured mostly in the group of pharmacists for which the information was integrated in their daily used software. These pharmacists asked significantly more about the patients' driving experience, informed them more about driving-related risk and gave more detailed information on impairing effects of medicines. The knowledge of the participating pharmacists on the topic 'medicines and driving' remained generally low. The participants acknowledge the importance of being aware of the topic medicines and driving but they report a lack of information or education. They strongly prefer a tool that integrates the information in their daily used software.
Conclusion: Dispensing support tools with information on the potential impairing effect of a medicine on the fitness to drive increases awareness, reported risk communication behaviour as well as knowledge of pharmacists on this topic. Computerised dispensing support tools are most effective when the information is integrated into the daily used dispensing software.
Similar articles
-
A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines.Int J Clin Pharm. 2014 Dec;36(6):1152-9. doi: 10.1007/s11096-014-0010-2. Epub 2014 Sep 10. Int J Clin Pharm. 2014. PMID: 25204257
-
Pharmacists' counseling on oral contraceptives: A theory informed analysis.Res Social Adm Pharm. 2016 Sep-Oct;12(5):669-81. doi: 10.1016/j.sapharm.2015.08.009. Epub 2015 Aug 29. Res Social Adm Pharm. 2016. PMID: 26386893
-
Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):610-7. doi: 10.1331/JAPhA.2014.14014. J Am Pharm Assoc (2003). 2014. PMID: 25343624
-
[Local Pharmacy Pharmacists' Responses to the Prescription of Drugs That Influence Driving].Yakugaku Zasshi. 2017;137(3):323-328. doi: 10.1248/yakushi.16-00237-3. Yakugaku Zasshi. 2017. PMID: 28250328 Review. Japanese.
-
[Driving ability, mental illness and psychotropic medication in the elderly].Rev Med Suisse. 2014 Apr 30;10(428):981-5. Rev Med Suisse. 2014. PMID: 24834622 Review. French.
Cited by
-
Community pharmacists' attitudes towards patient leaflets: Exploring perceptions underlying an electronic local production of tailored written information.AIMS Public Health. 2018 Jun 25;5(2):189-202. doi: 10.3934/publichealth.2018.2.189. eCollection 2018. AIMS Public Health. 2018. PMID: 30094280 Free PMC article.
-
A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines.Int J Clin Pharm. 2014 Dec;36(6):1152-9. doi: 10.1007/s11096-014-0010-2. Epub 2014 Sep 10. Int J Clin Pharm. 2014. PMID: 25204257
-
Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers.J Stud Alcohol Drugs. 2017 Nov;78(6):805-813. doi: 10.15288/jsad.2017.78.805. J Stud Alcohol Drugs. 2017. PMID: 29087813 Free PMC article.
-
People with insomnia: experiences with sedative hypnotics and risk perception.Health Expect. 2016 Aug;19(4):935-47. doi: 10.1111/hex.12388. Epub 2015 Aug 3. Health Expect. 2016. PMID: 26237994 Free PMC article.
-
Use of driving-impairing medicines by a Spanish population: a population-based registry study.BMJ Open. 2017 Nov 22;7(11):e017618. doi: 10.1136/bmjopen-2017-017618. BMJ Open. 2017. PMID: 29170289 Free PMC article.